This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
CADTH. Composite resin and amalgam dental filling materials: a review of safety, clinical effectiveness and cost-effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). 2012
Six randomized controlled trials were identified in the reviewed literature; each research question was evaluated in two trials. There was a strong evidence of amalgam safety when used in children 6 to 10 years old. However, there was limited information to evaluate the evidence of potential harms caused by composite. There was a suggestive evidence of longer longevity of dental amalgams than composites. Although the costs reported in the review may not reflect the Canadian prices, the long-term costs of both fillings suggest a relative cheaper price of amalgam material.
Subject indexing assigned by CRD
Cost-Benefit Analysis; Dental Amalgam; Dental Restoration, Permanent; Humans
Country of organisation
An English language summary is available.
Address for correspondence
Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, K1S 5S8 Ottawa, Ontario Canada Email: firstname.lastname@example.org
Date abstract record published